image
Avalo Therapeutics, Inc. AVTX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 12.41
-7.94 %
$ 129 M
Market Cap
0.13
P/E
BALANCE SHEET
21 M ASSETS
-37.08%
Growth Rates
1Year -37.08%
3Years -21.71%
5Years -21.46%
7Years 20.26%
10Years 15.25%
13.7 M LIABILITIES
-69.09%
Growth Rates
1Year -69.09%
3Years -10.65%
5Years -22.62%
7Years 13.73%
10Years -5.02%
7.3 M EQUITY
166.92%
Growth Rates
1Year 166.92%
3Years -33.25%
5Years -18.97%
7Years 66.37%
10Years 9.19%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Avalo Therapeutics, Inc.
image
Current Assets 8.4 M
Cash & Short-Term Investments 7.42 M
Receivables 136 K
Other Current Assets 844 K
Non-Current Assets 12.6 M
Long-Term Investments 0
PP&E 1.96 M
Other Non-Current Assets 10.6 M
Current Liabilities 4.62 M
Accounts Payable 446 K
Short-Term Debt 537 K
Other Current Liabilities 3.64 M
Non-Current Liabilities 9.07 M
Long-Term Debt 0
Other Non-Current Liabilities 9.07 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 7.4 13.2 54.6 18.9 3.6 10.6 2.5 5.1 21.2 11.7 3.4 9.5
Short Term Investments 0 0 0 0 7.6 0 0 0 0 0 0 0
Receivables 0.1 1.9 4.8 2.2 0 0.8 2.9 0.1 0 0 0 0
Inventory 0 20 K 38 K 3 K 21 K 1.1 0.4 11 K 0 0 0 0
Other Current Assets 0.8 1.3 2.4 4.9 1.9 10.1 4.9 0.4 0.5 0.4 0.7 0.4
Total Current Assets 8.4 16.4 61.8 26.0 17.7 21.9 11.0 5.7 21.6 12.2 4.1 9.9
PP&E 2.0 2.4 2.7 1.6 1.4 0.6 44.6 K 43 K 35 K 38.7 K 66 K 56.8 K
Intangible Assets 0 0 38 K 1.6 2.4 31.2 17.7 0 0 0 0 0
Goodwill 10.5 14.4 14.4 14.4 14.4 16.4 14.3 0 0 0 0 0
Long Term Investments 0 0.1 0.2 0.1 0.1 81.7 K 0.1 62.8 K 0 0 0 0
Other Long Term Assets 0.1 0.1 1.2 0.1 0.1 91.2 K 0.1 173 0 0.1 0.9 56.8 K
Other Assets 0 0 0 0 0 0 0 0 0 0 0 13.3 K
Total Assets 21.0 33.4 80.2 43.8 36.1 70.3 43.1 5.8 21.7 12.3 5.1 10.0
LIABILITIES
Accounts Payable 0.4 2.9 3.4 2.6 2.1 1.4 1.3 1.0 0.7 0.9 1.6 0.8
Short Term Debt 0.5 6.5 0.5 0.4 0.2 0 0 2.4 3.2 1.9 0 0
Other Current Liabilities 3.6 12.7 16.0 12.2 9.4 22.7 7.8 0.9 2.0 2.2 1.4 0.7
Total Current Liabilities 4.6 22.1 19.9 15.2 12.2 26.2 11.4 4.3 5.8 5.0 3.1 1.5
Long Term Debt 0 13.5 32.8 0 1.1 0 0 0 2.4 5.3 0 0
Deferred Tax Income 0.2 0.1 0.1 90 K 86 K 69.2 K 7.14 K 0 0 0 0 0
Other Liabilities 8.9 8.5 4.3 4.0 1.8 23.1 3.9 1.2 0.4 28.3 19.9 0
Total Liabilities 13.7 44.3 57.1 19.2 15.1 49.3 15.3 5.6 8.6 38.6 22.9 1.5
EQUITY
Common Stock 1 K 9 K 0.1 75 K 44 K 40.8 K 2.7 9.43 K 8.65 K 650 643 18 K
Retained Earnings (335.1) (303.8) (262.2) (177.8) (114.3) (98.2) (58.2) (70.0) (53.6) (43.1) (27.0) (14.0)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 0 2.7 0 (21 657.6) (28.3) (19.9) 0
Total Equity 7.3 (10.9) 23.1 24.6 21.0 20.9 27.9 0.2 13.1 (26.3) (17.8) 8.5
Total Liabilities and Equity 21.0 33.4 80.2 43.8 36.1 70.3 43.1 5.8 21.7 12.3 5.1 0
SHARES OUTSTANDING
Common Shares Outstanding 0.3 39.2 K 36.2 K 25.5 K 19.8 K 12.1 K 6.39 K 3.07 K 773 0 0 52.5 K